RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3%, to $457.25, ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
Robert F. Kennedy Jr.'s second confirmation hearing highlights vaccine skepticism, bipartisan concerns, and his plans as ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
President Donald Trump, in signing dozens of executive orders on Monday, rescinded an effort by former President Joe Biden to lower drug costs by directing Medicare and Medicaid to test models that ...
Medicare’s next drug price negotiations will treat ... rather than treat each use approved by the Food and Drug Administration separately. “The statute and our guidance [are] very clear that when a ...
Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...
Valentine's Day treats might look a little different in the next few years. The U.S. Food and Drug Administration has banned Red No. 3, a dye that gives food and drink a bright, cherry-red color.
Experts say the FDA’s move is a step forward in improving public health. The Food and Drug Administration (FDA) issued a nationwide ban on January 15 that will prohibit the use of red dye No. 3 ...